BioPharma Credit

Overview Performance Charges & gearing Portfolio Management Structure

Data as at: 19/01/2021

Website Company website
Objective
To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Management group
Pharmakon Advisors
AIC sector
Debt - Direct Lending
Launch date
27/03/2017
Financial year end
December
Domicile
United Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Total assets (m) Price (last close) Price (bid) Price (offer) NAV Dividend dates Discount / premium (%) Gearing (%) 5yr dividend growth (%) p.a. Dividend yield (%)
1,373.87 1.00 1.00 1.00 1.00 Mar, Jun, Sep, Dec 0.0 0 N/A 7.0

Dividends

Dividends displayed in traded currency.

Ex-Dividend date Dividend amount Dividend type Special dividend Financial year
19/11/2020 0.018 Income No 2020
19/11/2020 0.000 Income Yes 2020
20/08/2020 0.018 Income No 2020
21/05/2020 0.018 Income No 2020
27/02/2020 0.018 Income No 2019

View dividend history

Dividend cover (years) Revenue reserves (m)
0.43 41.69

Trading information

ISIN TIDM Traded currency
GB00BDGKMY29 BPCR USD

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 1,857,878 13,934,447 283,700,197 0
Average N/A 733,392 1,116,930 0

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 1.86 13.87 278.19 0
Average N/A 0.73 1.10 0

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.